METABOLIC GENE POLYMORPHISMS ASSOCIATED WITH ATOPIC BRONCHIAL ASTHMA
Ivaschenko TE1, Sideleva OG1, Zelenina LA2, Antonova EA2, Ostankova JV1, Aseev MV1, Baranov VS1
*Corresponding Author: Professor Dr. Vladislav S. Baranov, Ott’s Institute of Obstetrics/Gynecology, Russian Academy of Medical Sciences, Mendeleevskaya line 3, 199034 St. Petersburg, Russia; Tel/Fax: +07(812) 3280487 E-mail: baranov@vb2475.spb.edu
page: 23

MATERIALS AND METHODS

Patients and controls. The study group comprised 43 children (age range 10.2 ± 3.1 years) selected on the basis of ABA, patients from the Institute of Pulmonology and St. Olga’s Hospital in St. Petersburg, Russia. The characteristics of the recruited subjects are summarized in Table 1. The control group consisted of 51 healthy, unrelated subjects from St. Petersburg. Blood spots, collected on filter paper from each patient, were used directly for polymerase chain reaction (PCR), with or without prior DNA extraction.

PCR and PCR-RFLP (restriction fragment length polymorphism) analyses. GSTM1 and GSTT1 gene poly­morphism analyses were carried out, with slight modifica­tions as described elsewhere [10]. Co-amplification of a 192 bp DNA fragment of the CYPA1 gene (A1R: 5'-GAACTGCCACTTCAGCTGTCT-3'; A1F: 5'-GAAAGA CTCCCAGCGGTCA-3') was used throughout the study as a standard positive internal control for precise identification of the GSTM10/0 and GSTT10/0 genotypes. These were identified by the absence of the normal 271 bp DNA fragment typical for the GSTM1 active genotypes (GSTM1+/+ or GSTM1+/0), or a 315 bp DNA fragment typical for the GSTT1 active genotypes (GSTT1+/+ or GSTT1+/0).

A single PCR amplification was run with the following primers (GSTM1 F: 5'-GAACTCCCTGAAAA GCTAAAGC -3'; GSTM1 R: 5'-GTTGGGCTCAAATAT ACGGTGG-3'; and GST T1 F: 5'-TTCCTTACTGGTCC TCACATCTC -3'; GST T1 R: 5'-TCACCGGATCATGG CCAGCA-3'; 15 nM each in 25 mL amplification mixture plus 67 mM Tris-HCl (pH 8.8), 16.6 mM ammonium sulphate, 6.7 mM MgCl2, 6.7 mM EDTA, 10 mM mercapto­ethanol, 170 mg BSA, 1.0 mM of each dNTP, 1 U of Taq polymerase (Bion, Moscow, Russia). Denaturation (7 minutes at 94°C) was followed by 32 cycles of amplification: 1 minute at 94°C, 1 minute at 53°C, 1 minute 20 seconds at 72°C, and final extension for 7 minutes at 72°C. The products were subjected to electrophoresis on a 7% polyacrylamide gel, stained with ethidium bromide and visualized under UV light.

Three polymorphic alleles of the GSTP1 gene were identified: GSTP1*A (wild type Ile105/Ala114), GSTP1*B (Val105/Ala114), and GSTP1*C (Val105/ Val114) [11]. The Ile105/Val105 gene polymorphism in GSTP1 was examined after PCR amplification through the use of primers to exon 5 (GST p1 F: 5'-CTCTATGGGAA GGACCAGCAGGAG-3' and GST p2 R: 5'-CAAGCCAC CTGAGGGGTAAGG-3'). The PCR conditions were as follows: denaturation (7 minutes at 94°C) was followed by 32 cycles of amplification: 1 minute at 94°C, 1 minute at 60°C, 1 minute 20 seconds at 72°C, and final extension for 7 minutes at 72°C. The resulting 192 bp fragment was digested with BsoMoI1 to identify the A/G transition at nucleotied 1313. The undigested PCR product has the molecular length of 192 bp. The amplification product of the Val/Val type is cut into 80 and 112 bp fragments, respectively.

A PCR-based genotyping test was subsequently devel­oped for the detection of the Ala114/Val114 gene poly­morphism. This test used a reverse PCR primer with a 1 bp mismatch (GST p4 R: 5'-GCCTTCACATAGTCATCCT TGCGC-3' from exon 6, and a forward primer (GST p3 F: 5'-GTTGTGGGGAGCAAGCAGAGG-3') from intron 5. The mismatched primer introduced a BstFN1 site in the Ala114 allele but not in the Val114 allele. 

The PCR conditions were as follows: denaturation (7 minutes at 94°C) was followed by 32 cycles of amplification: 1 minute at 94°C, 1 minute at 60°C, 1 minute 20 seconds at 72°C, with a final extension at 72°C for 7 minutes. The resulting 142 bp products were digested overnight with 10 units of BstFN1 at 37°C, and the fragments were separated on a 7% polyacrylamide gel. Samples containing the Ala114 allele produced 121 and 25 bp fragments, respectively, after BstFN1 digestion, whereas the 142 bp product generated from the Val114 allele remained uncut.

Statistical analyses. A chi-square test (c2) was used for comparison of different polymorphic genotype distribution and their association with ABA. Statistical analyses were performed using Microsoft Excel (Microsoft Office 97). OR was estimated by the standard formula, OR = a/b x d/c, where a and b are the number of patients with or without the mutant genotype, respectively; c and d are the number of people in the control group with or without the mutant genotype, respectively. OR is specified with 95% confidential interval. Borders of a confidential interval were calculated under the following formulas: ORmin= OR(1-1,96/ ?_2) ORmax= OR(1+1,96/ v_2).

 

Table 1. Clinical parameters of the recruited subjects

 

 

 

n

 

%

 

Males

 

31

 

  72

 

Females

 

12

 

  28

 

Age range

 

10.2 ±3.1

 

 

Family history of disease

 

23

 

  52

 

Atopic dermatitis

 

29

 

  67

 

Positive skin test

 

43

 

100

 

Onset of the disease:
  Before age 7
  After age 7

 

3310

 

  76.0
  24.0

 

Course of the disease:
  Severe
  Moderate
  Mild

 

16
23
  4

 

  37.0
  54.0
    9.0

 

 

Table 2. Distribution of GSTM1, GSTT1 and GSTP1 genotypes in ABA children with respect to age of disease onset and atopic dermatitis [% (%)]

 

 

Genotype
 

 

Control
 

 

ABA Children
 

 

Disease Onset
 

 

Atopic Dermatitis
 

 

 

 

Before Age 7

After Age 7

Yes

No

 

GSTM10/0
GSTM1+

 

45.0 (23)?
55.0 (28)

 

79.0 (34)?
31.0 (9)

 

72.0 (24)
28.0 (9)

 

100.0 (10)
0

 

90.0 (26)‚
10.0 (3)

 

57.0 (8)‚
43.0 (6)

 

GSTT10/0
GSTT1+

 

20.0 (10)?
80.0 (41)

 

58.0 (25)?
42.0 (18)

 

55.0 (18)
45.0 (15)

 

  70.0 (7)
  30.0 (3)

 

62.0 (18)
38.0 (11)

 

50.0 (7)
50.0 (7)

 

GSTP1 A/A
GSTP1 A/B
GSTP1 A/C
GSTP1 B/B
GSTP1 B/C
GSTP1 C/C

 

53.0 (27)
25.0 (13)
16.0 (8)
  2.0 (1)
  2.0 (1)
  2.0 (1)

 

44.0 (19)
30.0 (13)
23.0 (10)
  2.0 (1)
  0
  0

 

46.0 (15)
21.0 (7)‚
30.0 (10)
  3.0 (1)
  0
  0

 

40.0 (4)
60.0 (6)‚
  0
  0
  0
  0

 

41.0 (12)
31.0 (9)
24.0 (7)
  3.0 (1)
  0
  0

 

50.0 (7)
29.0 (4)
21.0 (3)
  0
  0
  0

 

? p<0.001.

? p<0.01.

 




Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006